J
1.21
0.07 (6.14%)
| Previous Close | 1.14 |
| Open | 1.16 |
| Volume | 556,591 |
| Avg. Volume (3M) | 1,818,765 |
| Market Cap | 33,860,688 |
| Price / Book | 2.88 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2026 |
| Diluted EPS (TTM) | -5.27 |
| Total Debt/Equity (MRQ) | 6.13% |
| Current Ratio (MRQ) | 4.31 |
| Operating Cash Flow (TTM) | -69.71 M |
| Levered Free Cash Flow (TTM) | -43.72 M |
| Return on Assets (TTM) | -56.50% |
| Return on Equity (TTM) | -101.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Jasper Therapeutics, Inc. | Bearish | Bearish |
AIStockmoo Score
-1.0
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -1.00 |
|
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 1.27% |
| % Held by Institutions | 87.94% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Qiming U.S. Ventures Management, Llc | 30 Sep 2025 | 928,964 |
| Sphera Funds Management Ltd. | 31 Dec 2025 | 485,401 |
| Lion Point Capital, Lp | 31 Dec 2025 | 465,000 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |